Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prestige Consumer Healthcare Inc.
Bear Case (25th pct.)
32.5% vs price
Base Case (Median)
57.0% vs price
Bull Case (75th pct.)
74.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $176.14 | 288.0% | High (40%) |
| PE Comparable | $80.16 | 76.6% | Medium (25%) |
| Growth Trajectory DCF | $63.83 | 40.6% | Medium (20%) |
| Graham Number | $56.52 | 24.5% | Medium (40%) |
| EV/EBITDA | $40.22 | -11.4% | Medium (20%) |
| EV/FCF | $78.56 | 73.0% | Medium (20%) |
| Earnings Power Value | $71.28 | 57.0% | Medium (50%) |
Based on 7 out of 7 methods, PBH appears undervalued at the current price of $45.40. The base case fair value of $71.28 implies 57.0% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.